Dramatic Metabolic Response to Dual ICI With Chemotherapy in Low PD‐L1 NSCLC Case
ABSTRACT Despite low PD‐L1 (Programmed Death‐ligand 1) expression, this patient exhibited a dramatic positron emission tomography‐computed tomography response to dual immune checkpoint inhibitors with chemotherapy. This case highlights the potential benefits of combination therapy beyond traditional...
Saved in:
| Main Authors: | Toshikazu Kumasa, Akina Nigi, Keisuke Iwamoto, Hidetoshi Itani, Shigeto Kondou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Respirology Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/rcr2.70150 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational study
by: Alessandro Inno, et al.
Published: (2025-07-01) -
Anti-CTLA-and anti-PD-1 immune checkpoint inhibitor antibodies impair human sperm motility in-vitro
by: Ilaria Cosci, et al.
Published: (2025-03-01) -
Colitis grave inmunomediada por Nivolumab-Ipilimumab: a propósito de un caso
by: Maria Victoria Foglino, et al.
Published: (2025-07-01) -
INFLUENCE OF ANTIBODIES AGAINST CTLA-4 AND PD-1 UPON QUANTITIES OF THEIR TARGET RECEPTORS
by: I. O. Chikileva, et al.
Published: (2019-01-01) -
Pathologic complete response after laparoscopic surgery following treatment with nivolumab and ipilimumab for anticancer drug-resistant MSI-high descending colon cancer: a case report and literature review
by: Hiroshi Sawayama, et al.
Published: (2022-12-01)